
2020 News Coverage
Identifying Opportunities At The Interface Of Life Sciences And Tech
December 16, 2019| Mana Chandhok | Bio-IT World
A Regulatory View of Personalized TherapeuticsDecember 18, 2019 | Christina Lingham | Bio-IT World
Building Diagnostics With Data In Mind
December 18, 2019 | Kaitlin Searfoss Kelleher | Diagnostics World News
Scaling Precision Oncology
November 19, 2019 | Benjamin Ross | Diagnostics World News
A Digital Transformation at the City of Hope
December 19, 2019 | Mana Chandhok | Bio-IT World
2019 News Coverage
Young Scientists Present Diagnostic Solutions At Molecular Medicine Tri-Conference
April 10, 2019 | Benjamin Ross | Diagnostics World News
Point-Of-Care Testing And Diagnostics In Vietnam
April 9, 2019 | Benjamin Ross | Diagnostics World News
Microfluidic technologies are taking point-of-care testing to the next level
Mar 29, 2019 | Sébastien Clerc | Yole Development
Harnessing Machine Learning and Artificial Intelligence To Accelerate Discovery In Diagnostics
Mar 28, 2019 | Melissa Pandika | Diagnostics World News
Sarah Gray And Arupa Ganguly on Remembering The Human Lives Behind Biospecimen Donations
Mar 28, 2019 | Melissa Pandika | Bio-IT World
Harnessing Machine Learning And Artificial Intelligence To Accelerate Discoveries: Updates From Bio-IT World West
Mar 26, 2019 | Melissa Pandika | Bio-IT World
How Mount Sinai Placed A Clinical Trial In The Palm Of Your Hand
March 22, 2019 | Benjamin Ross | Clinical Research News
Evolving Challenges And Directions In Data Commons: Updates From Bio-IT World West
Mar 22, 2019 | Melissa Pandika | Bio-IT World
Building A Credit Score For Health: Sapiens Data Science's Approach to Precision Medicine
Mar 20, 2019 | Benjamin Ross | Diagnostics World News
Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine
Mar 15, 2019 | Monica Heger | GenomeWeb
Novel Technologies, Machine Learning Are The Keys To Improving Acute Infection Diagnostics
February 13, 2019 | Kaitlin Kelleher | Diagnostics World News
Rapid Response And The Outbreaks To Come
February 1, 2019 | Kaitlin Kelleher | Diagnostics World News
Collaboration And Machine Learning Key For 23andMe's Drug Discovery
January 31, 2019 | Mana Chandhok | Bio-IT World
EMERSE: How Better Big Data Search Could Change Healthcare
January 16, 2019 | Bio-IT World
2018 News Coverage
NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy
May 16, 2019 | Christie Rizk | GenomeWeb
The Latest in Data Integration and Personalized Medicine: Updates from the 2018 Molecular Medicine Tri-Conference
March 5, 2018 | Melissa Pandika | Bio-IT World
UCLA Leverages Lab Standardization to Evaluate New POC Testing
March 12, 2018 | GenomeWeb Staff | GenomeWeb
As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development
February 28, 2018 | Molika Ashford | GenomeWeb
TriCore Considering Broader Launch of 16S Metagenomic Assay for Bacterial Dx
February 28, 2018 | John Gilmore | GenomeWeb
Leroy Hood On How Systems-Driven 21st Century Medicine Could Transform Healthcare
February 27, 2018 | Melissa Pandika | Diagnotics World
Share The Data: David Haussler Envisions A New Future For Pediatric Cancer
February 22, 2018 | Leah Rosenbaum | Bio-IT World
Cofactor Pushes RNA-Based Dx Goals With New Immuno-Oncology Assay
February 16, 2018 | Molika Ashford | GenomeWeb
Startup Anitoa Systems Opens Early-Access Program for Portable qPCR System
February 15, 2018 | Madeleine Johnson | GenomeWeb
Diagnostics World Announces Winner Of Early Innovator Awards Program
February 14, 2018 | Diagnotics World Staff | Diagnotics World
UCSC Pediatric Cancer Effort Finds Success Using Gene Expression Data to Match Patients to Treatments
February 14, 2018 | Christie Rizk | GenomeWeb
2017 News Coverage
Dutch Team Refining Blood-Based Dx Platform Acquired by Illumina Last Year
Mar 10, 2017 | Justin Petrone | GenomeWeb
Startup TwinStrand Biosciences Aims to Commercialize Duplex Sequencing Technology
Mar 09, 2017 | Monica Heger | GenomeWeb
Integrated Future: GeneInsight’s New Home At Sunquest
March 6, 2017 | By Allison Proffitt | Bio-IT World
An Industry Goes for the Gut
March 2, 2017 | Regina McEnery | eureka
Despite Actionable Results, Cancer Sequencing Projects Struggle to Get Patients on Targeted Drugs
Mar 01, 2017 | Monica Heger | GenomeWeb
Raw Materials: iSpecimen Marketplace Platform Makes It Easy To Find Biospecimens
February 24, 2017 | By Allison Proffitt | Bio-IT World
UCSF Lab Readies Launch of Metagenomic NGS Test for Infectious Disease
Feb 24, 2017 | Monica Heger | GenomeWeb
An Immunological Ignition Switch
February 23, 2017 | Regina McEnery | eureka
Our Body’s Natural Born
February 22, 2017 | Regina McEnery | eureka
Diagnostics World Announces Winner of Inaugural Early Innovator Awards Program
February 22, 2017 | By Diagnostics World Staff | Diagnostics World
2016 News Coverage
Biocept's Dual Platform for Liquid Biopsies
March 15, 2016 | Aaron Krol | Diagnostics World
Notes from the 2016 Molecular Medicine Tri-Conference
March 14, 2016 | Diagnostics World Staff | Diagnostics World
Xcell's New Incubator Promises Lifelike Conditions for Tests on Primary Cells
March 14, 2016 | Aaron Krol | Diagnostics World
At Tri-Con, Groups Detail NGS-Based Strategies to Detect ctDNA Mutations at Ever-Lower Frequencies
March 11, 2016 | Monica Heger | GenomeWeb
Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con
March 9, 2016 | Ben Butkus | GenomeWeb
Must See Talks on Big Data and Informatics at TRI-CON 2016
February 10, 2016 | Zachary Helminiak | SLONE Partners
Molecular Medicine Tri-Conference in San Francisco March 6-11; BioQuick News Is a Media Sponsor
February 20, 2016 | Staff Writer | bioquicknews
10 Must See Talks at TRI-CON 2016
February 10, 2016 | Zachary Helminiak | SLONE Partners
Visit the preeminent event on molecular medicine
February 1, 2016 | Lloyd Dunlap | DDNews
Fluoresentric on the Right Pitch to Capitalize a Diagnostic Technology
August 4, 2015 | Diagnostics World Staff | Diagnostics World
2015 News Coverage
TRICON: HI’s Molecular Medicine Tri-Conference Kicks Off Despite Holiday, Slowed Travel
February 16, 2015 | BioSpace | Riley McDermid
Maverix Biomics and Elsevier Sign NGS Data Interpretation Agreement
February 16, 2015 | Bio-IT World Staff | Bio-IT World
BIOVIA Launches Biologics Informatics Program
February 17, 2015 | Bio-IT World Staff | Bio-IT World
News and Notes from TriCon 2015
February 19, 2015 | Bio-IT World Staff | Bio-IT World
Guardant Health, Collaborators Present Clinical Validity Data for ctDNA Assay
February 20, 2015 | Monica Heger | GenomeWeb
Multiplicom, Premaitha Develop CE-IVDs for Noninvasive Prenatal Testing in Europe
February 24, 2015 | Monica Heger | GenomeWeb
Personal Genome Diagnostics Aims for FDA Clearance of NGS-based Cancer Products
February 24, 2015 | Monica Heger | GenomeWeb
Reporter’s Notebook: Molecular Medicine Tri Conference 2015
February 27, 2015 | Aaron Krol | Bio-IT World
Point-of-Care Diagnostics at the 22nd International Molecular Medicine Tri-Conference
April 22, 2015 | Robert L Stevenson, PhD | American Laboratory
2014 News Coverage
With New Tools, Physicians Become Better NGS Customers
Mar 15 | GEN | Scientists who study how physicians use genomics data in personalized medicine presented
their recent work at the Cambridge Healthtech Molecular Med Tri Conference in San Francisco.
Startup Guardant Health Developing NGS-based Assays to Assess Circulating Tumor DNA
Mar 5 | Clinical Sequencing News | At last month's Molecular Medicine Tri-Conference in San
Francisco, Dave Hoon, the director of the John Wayne Cancer Institute's sequencing center
and an advisor to the company, presented a validation study he is doing with the company,
results of which have been analyzed in around 250 patients so far.
Singapore's MiRxes Spins Out from A*Star with Novel qPCR Assay Platform for microRNA Analysis
Feb 27 | MiRxes CTO Lihan Zhou and other company officials presented posters describing
the mSMRT-qPCR technology and MiRxes' efforts to apply it to the non-invasive early
detection of gastric and breast cancers earlier this month at Cambridge Healthtech
Institute's Molecular Medicine Tri-Conference in San Francisco.
Q&A: UMich's Muneesh Tewari on miRNAs as Cancer Biomarkers, ddPCR as Detection Method
Feb 27 | PCR Insider | Earlier this month at Cambridge Healthtech Institute's Molecular
Medicine Tri-Conference in San Francisco, Tewari presented some of his recent work
in this area. He highlighted the fact that research on circulating miRNAs as cancer
biomarkers is now nearing the six-year mark, and reviewed what researchers have
learned and where they go from here.
UCSF, QB3 Team Developing PCR-Activated Cell Sorting Method; Startup Mission Bio Eyes Market
Feb 20 | PCR Insider | Abate shared details of the new method in a presentation
last week at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference
in San Francisco.
MolecularHealth Readies NGS-based Oncology Assays
Feb 19 | Clinical Sequencing News | MolecularHealth is in the final stages
of validating a targeted sequencing panel and an exome sequencing test
for cancer patients and plans to launch the tests within the next couple
of months, the company told Clinical Sequencing News at last week's Molecular
Medicine Tri Conference in San Francisco.
Patient Stratification in Clinical Trials Emerges as Theme at MMTC
Feb 17 | Bio-IT World | The 21st annual Molecular Medicine Tri-Conference
in San Francisco featured some intense scrutiny of one area where genetic
knowledge is ready to make an impact today: better defining the best
patient populations for treatment during clinical trials.
At Threshold of Detection, False-Positive Droplets a Nuisance in ddPCR
Feb 13 | PCR Insider | In a presentation this week at Cambridge Healthtech
Institute's Molecular Medicine Tri-Conference in San Francisco,
Strain stated definitively that real-time PCR is "not good enough"
for the detection of residual HIV nucleic acids in patient samples,
and provided additional evidence generated in his lab that droplet
digital PCR is an ideal modality for this application.
Rheonix Unveils 'Channel-Free' Microfluidic Device for Molecular Testing Platform
Feb 13 | PCR Insider | In a presentation in the Biospecimen Science
and Sample Prep program of Cambridge Healthtech Institute's
Molecular Medicine Tri-Conference, held here this week, Richard
Montagna, Rheonix's senior vice president for scientific and
clinical affairs, discussed the company's latest microfluidics
breakthrough, the Smart FilmCARD.
Denmark's Anapa Biotech Applies Primer-Modification Tech to MRSA Assay; Discloses NextGen Molecule
Feb 13 | PCR Insider | Schneider discussed these developments
at a presentation during the "PCR for Molecular Medicine"
track at Cambridge Healthcare Institute's Molecular Medicine
Tri-Conference, held here this week.
Sample Prep Proving a Key Consideration in Clinical NGS Testing
Feb 12 | Clinical Sequencing News | Increasingly, issues
related to sample prep, not sequencing technology,
are becoming the hurdle for developing clinical next-gen
sequencing-based tests, researchers from Quest Diagnostics
and the US Centers for Disease Control and Prevention
said at this week's Molecular Medicine Tri Conference
in San Francisco.
Informatics Tools for the Big Data Challenge
Jan 03 | Bio-IT World |Informatics tools are essential
to enabling life sciences research, and at the
Molecular Medicine Tri-Conference next month in
San Francisco, a host of leaders across the industry
will share their best practices for making sense
of the wealth.
Clinical Sequencing at the Molecular Medicine Tri-Conference
Jan 02 | Clinical Informatics News | 2014 will
be the biggest year yet for the clinical use
of genetic information. At the Molecular Medicine
Tri-Conference in February, speakers from biotech
industry and research will discuss the future
of clinical sequencing, whether in cancer treatment,
diagnostics, prenatal testing, or just general
care.
Maven Biotech Undertakes Asset Sale to Deliver Label-free Detection Technology into 'Stronger Hands'
Dec 17 | BioArray News| Blose said that Maven's
technology is "already receiving attention"
from undisclosed parties, and that BioMed
intends to meet with potential partners
at the upcoming JP Morgan Healthcare Conference
in San Francisco in January, and again
at the Molecular Medicine Tri-Conference,
which will also be held in San Francisco,
in February.